Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Purpura, Thrombotic Thrombocytopenic | 10 | 2024 | 131 | 3.480 |
Why?
|
Thrombotic Microangiopathies | 7 | 2023 | 123 | 2.760 |
Why?
|
Platelet Transfusion | 5 | 2023 | 298 | 2.330 |
Why?
|
Isoantibodies | 5 | 2019 | 674 | 1.700 |
Why?
|
HLA Antigens | 6 | 2019 | 1328 | 1.510 |
Why?
|
Thrombocytopenia | 6 | 2020 | 1182 | 1.380 |
Why?
|
Blood Transfusion | 5 | 2023 | 1301 | 1.350 |
Why?
|
Erythrocytes, Abnormal | 2 | 2023 | 121 | 1.330 |
Why?
|
Plasma Exchange | 6 | 2024 | 159 | 1.170 |
Why?
|
Blood Component Transfusion | 2 | 2024 | 142 | 0.990 |
Why?
|
Hematologic Agents | 1 | 2024 | 40 | 0.920 |
Why?
|
ADAM Proteins | 3 | 2024 | 238 | 0.730 |
Why?
|
Blood Platelets | 4 | 2023 | 2479 | 0.690 |
Why?
|
Hematologic Diseases | 1 | 2023 | 496 | 0.660 |
Why?
|
Acute Lung Injury | 2 | 2012 | 367 | 0.540 |
Why?
|
Anemia, Hemolytic, Autoimmune | 2 | 2008 | 147 | 0.540 |
Why?
|
Gerstmann Syndrome | 1 | 2016 | 4 | 0.540 |
Why?
|
Platelet Count | 4 | 2023 | 781 | 0.510 |
Why?
|
Cytapheresis | 1 | 2015 | 8 | 0.510 |
Why?
|
Blood Donors | 3 | 2019 | 345 | 0.480 |
Why?
|
Middle Cerebral Artery | 1 | 2016 | 275 | 0.470 |
Why?
|
Spleen | 1 | 2020 | 2295 | 0.460 |
Why?
|
Polycythemia | 1 | 2015 | 124 | 0.460 |
Why?
|
Hematopoietic Stem Cell Mobilization | 1 | 2015 | 225 | 0.460 |
Why?
|
Blood Cells | 1 | 2016 | 305 | 0.460 |
Why?
|
Erythrocytes | 2 | 2023 | 2413 | 0.440 |
Why?
|
Blood Component Removal | 1 | 2014 | 132 | 0.440 |
Why?
|
Thrombopoietin | 2 | 2019 | 226 | 0.410 |
Why?
|
Infarction, Middle Cerebral Artery | 1 | 2016 | 485 | 0.410 |
Why?
|
Paraproteinemias | 1 | 2015 | 248 | 0.410 |
Why?
|
Fetomaternal Transfusion | 1 | 2012 | 10 | 0.400 |
Why?
|
Hematopoietic Stem Cells | 2 | 2015 | 3397 | 0.400 |
Why?
|
Receptors, Thrombopoietin | 1 | 2013 | 160 | 0.400 |
Why?
|
Cryoglobulins | 2 | 2008 | 58 | 0.390 |
Why?
|
Receptors, LDL | 3 | 2000 | 488 | 0.370 |
Why?
|
Intensive Care Units | 1 | 2024 | 3744 | 0.370 |
Why?
|
Erythropoietin | 1 | 2015 | 719 | 0.360 |
Why?
|
Postoperative Hemorrhage | 1 | 2014 | 415 | 0.360 |
Why?
|
Wounds and Injuries | 1 | 2023 | 2492 | 0.340 |
Why?
|
Autoantibodies | 4 | 2024 | 2118 | 0.340 |
Why?
|
Donor Selection | 1 | 2011 | 232 | 0.320 |
Why?
|
Activated Protein C Resistance | 1 | 2008 | 18 | 0.320 |
Why?
|
CCAAT-Enhancer-Binding Proteins | 2 | 2000 | 286 | 0.300 |
Why?
|
Microspheres | 1 | 2011 | 784 | 0.290 |
Why?
|
Anemia, Sickle Cell | 1 | 2016 | 1063 | 0.290 |
Why?
|
International Normalized Ratio | 2 | 2024 | 382 | 0.270 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2023 | 9001 | 0.270 |
Why?
|
Hemolysis | 1 | 2008 | 415 | 0.260 |
Why?
|
ABO Blood-Group System | 1 | 2008 | 380 | 0.250 |
Why?
|
Antigen-Presenting Cells | 1 | 2008 | 964 | 0.240 |
Why?
|
Recombinant Proteins | 2 | 2024 | 6534 | 0.230 |
Why?
|
Kidney Diseases | 1 | 2015 | 2091 | 0.230 |
Why?
|
Severity of Illness Index | 4 | 2020 | 15843 | 0.230 |
Why?
|
Leukocytes | 1 | 2012 | 2026 | 0.230 |
Why?
|
Humans | 58 | 2024 | 761596 | 0.220 |
Why?
|
Immunoglobulin M | 1 | 2008 | 1526 | 0.220 |
Why?
|
Encephalitis, Herpes Simplex | 1 | 2003 | 65 | 0.210 |
Why?
|
Antigen Presentation | 1 | 2008 | 1251 | 0.210 |
Why?
|
Antigens | 1 | 2008 | 1443 | 0.210 |
Why?
|
Critical Care | 3 | 2024 | 2697 | 0.200 |
Why?
|
Antigen-Antibody Complex | 1 | 2024 | 510 | 0.200 |
Why?
|
Purpura, Thrombocytopenic, Idiopathic | 2 | 2019 | 242 | 0.200 |
Why?
|
Cell Shape | 1 | 2023 | 371 | 0.200 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2008 | 1349 | 0.190 |
Why?
|
Clinical Laboratory Techniques | 4 | 2014 | 746 | 0.190 |
Why?
|
Flow Cytometry | 1 | 2012 | 5870 | 0.190 |
Why?
|
Sterols | 2 | 1998 | 64 | 0.180 |
Why?
|
Plasma | 1 | 2024 | 586 | 0.180 |
Why?
|
Disseminated Intravascular Coagulation | 1 | 2020 | 186 | 0.170 |
Why?
|
Splenomegaly | 1 | 2020 | 189 | 0.170 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2024 | 664 | 0.170 |
Why?
|
Tacrolimus | 1 | 2023 | 733 | 0.170 |
Why?
|
Plateletpheresis | 1 | 2019 | 38 | 0.170 |
Why?
|
Anemia | 2 | 2010 | 1509 | 0.170 |
Why?
|
Infertility, Male | 1 | 2002 | 395 | 0.160 |
Why?
|
Blood Grouping and Crossmatching | 1 | 2019 | 100 | 0.160 |
Why?
|
Resuscitation | 1 | 2023 | 673 | 0.150 |
Why?
|
Hemostatics | 1 | 2020 | 241 | 0.150 |
Why?
|
Histocompatibility | 1 | 2019 | 317 | 0.150 |
Why?
|
Female | 27 | 2024 | 392705 | 0.150 |
Why?
|
Male | 26 | 2024 | 360846 | 0.150 |
Why?
|
Herpesvirus 1, Human | 1 | 2003 | 753 | 0.150 |
Why?
|
Hypertriglyceridemia | 1 | 2020 | 293 | 0.150 |
Why?
|
Pathology, Clinical | 2 | 2014 | 376 | 0.140 |
Why?
|
Antifibrinolytic Agents | 1 | 2020 | 292 | 0.140 |
Why?
|
Lymphocyte Activation | 1 | 2008 | 5485 | 0.140 |
Why?
|
Histocompatibility Testing | 1 | 2019 | 712 | 0.140 |
Why?
|
Lymphopenia | 1 | 2019 | 281 | 0.140 |
Why?
|
Cord Blood Stem Cell Transplantation | 1 | 2019 | 305 | 0.140 |
Why?
|
Middle Aged | 19 | 2024 | 220921 | 0.140 |
Why?
|
Infertility, Female | 1 | 2002 | 760 | 0.130 |
Why?
|
Diagnosis, Differential | 6 | 2016 | 12973 | 0.130 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2008 | 2155 | 0.130 |
Why?
|
Circulatory Arrest, Deep Hypothermia Induced | 1 | 2015 | 82 | 0.120 |
Why?
|
Prognosis | 4 | 2023 | 29629 | 0.120 |
Why?
|
Hematologic Tests | 1 | 2016 | 239 | 0.120 |
Why?
|
Aged | 15 | 2024 | 169310 | 0.120 |
Why?
|
Speech Disorders | 1 | 2016 | 180 | 0.120 |
Why?
|
Endarterectomy | 1 | 2015 | 196 | 0.120 |
Why?
|
Paracentesis | 1 | 2015 | 98 | 0.120 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2008 | 4580 | 0.120 |
Why?
|
Leukemia, T-Cell | 1 | 1994 | 101 | 0.120 |
Why?
|
Retrospective Studies | 9 | 2024 | 80647 | 0.120 |
Why?
|
Mitogens | 1 | 1994 | 230 | 0.120 |
Why?
|
Treatment Failure | 1 | 2020 | 2643 | 0.120 |
Why?
|
Adult | 18 | 2024 | 221210 | 0.110 |
Why?
|
Benzylamines | 1 | 2015 | 247 | 0.110 |
Why?
|
Urticaria | 1 | 2015 | 150 | 0.110 |
Why?
|
Heterocyclic Compounds | 1 | 2015 | 246 | 0.110 |
Why?
|
Antibodies | 3 | 2012 | 2418 | 0.110 |
Why?
|
IgA Deficiency | 1 | 2013 | 39 | 0.110 |
Why?
|
Pancreatitis | 1 | 2020 | 1096 | 0.110 |
Why?
|
Costs and Cost Analysis | 1 | 2019 | 1668 | 0.110 |
Why?
|
Heparin | 1 | 2020 | 1634 | 0.110 |
Why?
|
Immunity | 1 | 2019 | 996 | 0.110 |
Why?
|
Hematopoietic Stem Cell Transplantation | 2 | 2023 | 5672 | 0.110 |
Why?
|
Complement System Proteins | 2 | 2023 | 735 | 0.100 |
Why?
|
Electronic Mail | 1 | 2014 | 213 | 0.100 |
Why?
|
Polyneuropathies | 1 | 2014 | 137 | 0.100 |
Why?
|
Tetradecanoylphorbol Acetate | 3 | 2000 | 817 | 0.100 |
Why?
|
Paraneoplastic Syndromes | 1 | 2014 | 155 | 0.100 |
Why?
|
Blood Safety | 1 | 2012 | 16 | 0.100 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2015 | 629 | 0.100 |
Why?
|
Rosette Formation | 1 | 2012 | 152 | 0.100 |
Why?
|
Albumins | 1 | 2015 | 575 | 0.100 |
Why?
|
Rh Isoimmunization | 1 | 2012 | 23 | 0.100 |
Why?
|
Antigens, CD34 | 1 | 2014 | 658 | 0.100 |
Why?
|
Rho(D) Immune Globulin | 1 | 2012 | 34 | 0.100 |
Why?
|
Drug Evaluation | 1 | 2013 | 641 | 0.100 |
Why?
|
Benzoates | 1 | 2013 | 212 | 0.100 |
Why?
|
Hydrazines | 1 | 2013 | 224 | 0.100 |
Why?
|
Thrombopoiesis | 1 | 2013 | 165 | 0.100 |
Why?
|
Antiphospholipid Syndrome | 1 | 2013 | 165 | 0.100 |
Why?
|
Rh-Hr Blood-Group System | 1 | 2012 | 63 | 0.100 |
Why?
|
Cold Temperature | 1 | 2015 | 785 | 0.100 |
Why?
|
Bone Marrow Diseases | 1 | 2013 | 233 | 0.100 |
Why?
|
Prothrombin Time | 2 | 2008 | 117 | 0.090 |
Why?
|
Acids | 1 | 2012 | 125 | 0.090 |
Why?
|
Leukocyte Count | 1 | 2015 | 1596 | 0.090 |
Why?
|
Cohort Studies | 6 | 2020 | 41495 | 0.090 |
Why?
|
Chromosome Aberrations | 2 | 1994 | 1768 | 0.090 |
Why?
|
Immunosuppressive Agents | 1 | 2023 | 4176 | 0.090 |
Why?
|
Nerve Fibers | 1 | 2014 | 708 | 0.090 |
Why?
|
Fetal Blood | 2 | 2019 | 1347 | 0.090 |
Why?
|
Solubility | 1 | 2012 | 1091 | 0.090 |
Why?
|
Immunologic Factors | 1 | 2019 | 1590 | 0.090 |
Why?
|
Hemophilia A | 1 | 2013 | 360 | 0.080 |
Why?
|
Receptors, Fc | 1 | 2013 | 535 | 0.080 |
Why?
|
Cystadenocarcinoma, Serous | 1 | 1994 | 478 | 0.080 |
Why?
|
Thromboembolism | 1 | 2016 | 995 | 0.080 |
Why?
|
Fatal Outcome | 1 | 2014 | 1835 | 0.080 |
Why?
|
Disease Management | 1 | 2020 | 2508 | 0.080 |
Why?
|
Fetal Hemoglobin | 1 | 2012 | 345 | 0.080 |
Why?
|
Sterol Regulatory Element Binding Protein 1 | 2 | 2000 | 135 | 0.080 |
Why?
|
Erythrocyte Aggregation | 1 | 2008 | 35 | 0.080 |
Why?
|
Syndrome | 1 | 2015 | 3267 | 0.080 |
Why?
|
Immunoglobulin Idiotypes | 1 | 1988 | 200 | 0.080 |
Why?
|
Acute Disease | 3 | 2020 | 7237 | 0.080 |
Why?
|
Antibodies, Antiphospholipid | 1 | 2008 | 71 | 0.080 |
Why?
|
Nuclear Proteins | 2 | 2000 | 5799 | 0.080 |
Why?
|
Pathology Department, Hospital | 1 | 2007 | 10 | 0.080 |
Why?
|
Headache | 1 | 2016 | 1256 | 0.070 |
Why?
|
Genes, Immunoglobulin | 1 | 1988 | 285 | 0.070 |
Why?
|
Retinal Diseases | 1 | 2014 | 705 | 0.070 |
Why?
|
Jurkat Cells | 2 | 2000 | 740 | 0.070 |
Why?
|
Immunoglobulin Variable Region | 1 | 1988 | 419 | 0.070 |
Why?
|
Treatment Outcome | 5 | 2024 | 64685 | 0.070 |
Why?
|
Staining and Labeling | 1 | 2012 | 1085 | 0.070 |
Why?
|
Heating | 1 | 2008 | 104 | 0.070 |
Why?
|
Recombinant Fusion Proteins | 2 | 2013 | 3733 | 0.070 |
Why?
|
Academic Medical Centers | 2 | 2014 | 2759 | 0.070 |
Why?
|
Lupus Nephritis | 1 | 2010 | 317 | 0.070 |
Why?
|
Ionomycin | 2 | 1998 | 110 | 0.070 |
Why?
|
Salvage Therapy | 1 | 2013 | 1263 | 0.070 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2019 | 4369 | 0.070 |
Why?
|
Wiskott-Aldrich Syndrome Protein, Neuronal | 1 | 2006 | 87 | 0.070 |
Why?
|
Antibody Specificity | 1 | 2008 | 1060 | 0.070 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 3810 | 0.070 |
Why?
|
Length of Stay | 2 | 2020 | 6426 | 0.070 |
Why?
|
Insulin | 1 | 2020 | 6597 | 0.070 |
Why?
|
Immunoglobulin Heavy Chains | 1 | 1988 | 647 | 0.060 |
Why?
|
Rabbits | 1 | 2012 | 4772 | 0.060 |
Why?
|
DNA-Binding Proteins | 2 | 2000 | 9610 | 0.060 |
Why?
|
Liability, Legal | 1 | 2007 | 210 | 0.060 |
Why?
|
Heart Valve Diseases | 1 | 2013 | 1027 | 0.060 |
Why?
|
Reproducibility of Results | 1 | 2023 | 20100 | 0.060 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2020 | 3615 | 0.060 |
Why?
|
Waldenstrom Macroglobulinemia | 1 | 2014 | 1073 | 0.060 |
Why?
|
Consensus | 1 | 2014 | 3124 | 0.060 |
Why?
|
Immunization | 1 | 2008 | 1227 | 0.060 |
Why?
|
Time Factors | 2 | 2024 | 39969 | 0.060 |
Why?
|
Patient Selection | 2 | 2013 | 4244 | 0.060 |
Why?
|
Aortic Valve | 1 | 2013 | 1955 | 0.050 |
Why?
|
Transcription Factors | 2 | 2000 | 12130 | 0.050 |
Why?
|
Retina | 1 | 2014 | 2659 | 0.050 |
Why?
|
Pyrazoles | 1 | 2013 | 2009 | 0.050 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2013 | 1553 | 0.050 |
Why?
|
Ovulation Detection | 1 | 2002 | 5 | 0.050 |
Why?
|
Colombia | 1 | 2003 | 282 | 0.050 |
Why?
|
Tubulin | 1 | 2006 | 693 | 0.050 |
Why?
|
Base Sequence | 4 | 2000 | 12441 | 0.050 |
Why?
|
Kidney | 2 | 2023 | 7048 | 0.050 |
Why?
|
Pulmonary Embolism | 1 | 2015 | 2567 | 0.050 |
Why?
|
Spinal Puncture | 1 | 2003 | 282 | 0.050 |
Why?
|
Temperature | 1 | 2008 | 2226 | 0.050 |
Why?
|
Mycophenolic Acid | 1 | 2023 | 349 | 0.050 |
Why?
|
Models, Biological | 1 | 2017 | 9469 | 0.040 |
Why?
|
Ovarian Neoplasms | 2 | 1994 | 4878 | 0.040 |
Why?
|
Aortic Aneurysm, Abdominal | 1 | 2010 | 1228 | 0.040 |
Why?
|
Skin | 1 | 2014 | 4484 | 0.040 |
Why?
|
Protein Synthesis Inhibitors | 1 | 2000 | 189 | 0.040 |
Why?
|
Cycloheximide | 1 | 2000 | 343 | 0.040 |
Why?
|
Blood Vessel Prosthesis Implantation | 1 | 2010 | 1428 | 0.040 |
Why?
|
Risk | 1 | 2012 | 9610 | 0.040 |
Why?
|
Vaccines | 1 | 2008 | 844 | 0.040 |
Why?
|
Semen | 1 | 2002 | 347 | 0.040 |
Why?
|
Pregnancy | 3 | 2012 | 29890 | 0.040 |
Why?
|
DNA Probes | 1 | 2000 | 541 | 0.040 |
Why?
|
Genes, Regulator | 1 | 2000 | 373 | 0.040 |
Why?
|
von Willebrand Factor | 1 | 2023 | 673 | 0.040 |
Why?
|
Germ Cells | 1 | 2023 | 634 | 0.040 |
Why?
|
Sensitivity and Specificity | 2 | 2012 | 14665 | 0.040 |
Why?
|
Actins | 1 | 2006 | 2050 | 0.040 |
Why?
|
Living Donors | 1 | 2023 | 641 | 0.040 |
Why?
|
Chloramphenicol O-Acetyltransferase | 1 | 1998 | 221 | 0.040 |
Why?
|
Ionophores | 1 | 1998 | 107 | 0.040 |
Why?
|
Renal Replacement Therapy | 1 | 2020 | 282 | 0.040 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 1994 | 8554 | 0.040 |
Why?
|
Sterol Regulatory Element Binding Protein 2 | 1 | 1998 | 57 | 0.040 |
Why?
|
Medical History Taking | 1 | 2002 | 774 | 0.040 |
Why?
|
Steroids | 1 | 2023 | 929 | 0.040 |
Why?
|
Promoter Regions, Genetic | 2 | 2000 | 5790 | 0.040 |
Why?
|
Travel | 1 | 2003 | 796 | 0.040 |
Why?
|
Cytomegalovirus Infections | 1 | 2003 | 831 | 0.030 |
Why?
|
Endothelium, Vascular | 1 | 2009 | 4431 | 0.030 |
Why?
|
Tumor Cells, Cultured | 2 | 1994 | 6131 | 0.030 |
Why?
|
DNA, Viral | 1 | 2003 | 2202 | 0.030 |
Why?
|
Immunoglobulin G | 1 | 2008 | 4544 | 0.030 |
Why?
|
Vasodilator Agents | 1 | 2020 | 973 | 0.030 |
Why?
|
Genes, Reporter | 1 | 2000 | 1529 | 0.030 |
Why?
|
Physical Examination | 1 | 2002 | 1255 | 0.030 |
Why?
|
Fever | 1 | 2003 | 1618 | 0.030 |
Why?
|
Sequence Deletion | 1 | 2000 | 1494 | 0.030 |
Why?
|
Temporal Lobe | 1 | 2003 | 1695 | 0.030 |
Why?
|
Transfection | 2 | 2006 | 5774 | 0.030 |
Why?
|
Karyotyping | 2 | 1994 | 1171 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2012 | 10212 | 0.030 |
Why?
|
Early Diagnosis | 1 | 2020 | 1186 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 2 | 2016 | 20568 | 0.030 |
Why?
|
Germ-Line Mutation | 1 | 2023 | 1858 | 0.030 |
Why?
|
Chromosome Banding | 1 | 1994 | 260 | 0.030 |
Why?
|
Molecular Sequence Data | 3 | 2000 | 17635 | 0.030 |
Why?
|
Polymerase Chain Reaction | 1 | 2003 | 6075 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 2 | 2016 | 36426 | 0.030 |
Why?
|
Physician Executives | 1 | 2014 | 134 | 0.030 |
Why?
|
Work | 1 | 2014 | 195 | 0.030 |
Why?
|
Ascites | 1 | 2015 | 338 | 0.030 |
Why?
|
Laboratories, Hospital | 1 | 2014 | 192 | 0.030 |
Why?
|
Triglycerides | 1 | 2020 | 2461 | 0.030 |
Why?
|
Periodicity | 1 | 2014 | 348 | 0.030 |
Why?
|
Immunotherapy | 1 | 2008 | 4652 | 0.030 |
Why?
|
Fundus Oculi | 1 | 2014 | 556 | 0.030 |
Why?
|
Electroretinography | 1 | 2014 | 525 | 0.020 |
Why?
|
Equipment Design | 1 | 2019 | 3511 | 0.020 |
Why?
|
Risk Factors | 3 | 2015 | 74213 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2020 | 6312 | 0.020 |
Why?
|
Seizures | 1 | 2003 | 2957 | 0.020 |
Why?
|
Northern Ireland | 1 | 2010 | 37 | 0.020 |
Why?
|
RNA, Messenger | 2 | 1998 | 12794 | 0.020 |
Why?
|
Graft Rejection | 1 | 2023 | 4446 | 0.020 |
Why?
|
Hospitals, General | 1 | 2014 | 798 | 0.020 |
Why?
|
Animals | 4 | 2012 | 168475 | 0.020 |
Why?
|
Pilot Projects | 1 | 2023 | 8633 | 0.020 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2023 | 3080 | 0.020 |
Why?
|
Respiration, Artificial | 1 | 2020 | 2630 | 0.020 |
Why?
|
Young Adult | 1 | 2016 | 59260 | 0.020 |
Why?
|
Blood Loss, Surgical | 1 | 2013 | 638 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2019 | 6815 | 0.020 |
Why?
|
Gene Rearrangement, B-Lymphocyte | 1 | 1988 | 111 | 0.020 |
Why?
|
Fluorescein Angiography | 1 | 2014 | 1059 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2019 | 6484 | 0.020 |
Why?
|
Confusion | 1 | 2010 | 278 | 0.020 |
Why?
|
Propensity Score | 1 | 2016 | 1913 | 0.020 |
Why?
|
Thrombospondins | 1 | 2009 | 194 | 0.020 |
Why?
|
Aortography | 1 | 2010 | 421 | 0.020 |
Why?
|
Binding, Competitive | 1 | 2009 | 1141 | 0.020 |
Why?
|
Blood Coagulation | 1 | 2013 | 1154 | 0.020 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 1992 | 1246 | 0.020 |
Why?
|
Aortic Rupture | 1 | 2010 | 319 | 0.020 |
Why?
|
Cell Membrane Structures | 1 | 2006 | 24 | 0.020 |
Why?
|
DNA | 2 | 1998 | 7213 | 0.020 |
Why?
|
Recurrence | 1 | 2019 | 8466 | 0.020 |
Why?
|
Cross Reactions | 1 | 1988 | 817 | 0.020 |
Why?
|
Cortactin | 1 | 2006 | 27 | 0.020 |
Why?
|
Actin-Related Protein 2-3 Complex | 1 | 2006 | 61 | 0.020 |
Why?
|
Fluorescence Resonance Energy Transfer | 1 | 2009 | 421 | 0.020 |
Why?
|
Central Nervous System Diseases | 1 | 2010 | 520 | 0.020 |
Why?
|
Transcription, Genetic | 1 | 2000 | 7593 | 0.020 |
Why?
|
Child | 1 | 2014 | 80158 | 0.020 |
Why?
|
Immunoenzyme Techniques | 1 | 2009 | 1704 | 0.020 |
Why?
|
cdc42 GTP-Binding Protein | 1 | 2006 | 187 | 0.020 |
Why?
|
Multigene Family | 1 | 1988 | 1076 | 0.020 |
Why?
|
Minor Histocompatibility Antigens | 1 | 2006 | 293 | 0.020 |
Why?
|
Device Removal | 1 | 2010 | 630 | 0.020 |
Why?
|
Blood Vessel Prosthesis | 1 | 2010 | 951 | 0.020 |
Why?
|
Protein Kinases | 1 | 1992 | 1608 | 0.010 |
Why?
|
Prosthesis-Related Infections | 1 | 2010 | 487 | 0.010 |
Why?
|
Prosthesis Failure | 1 | 2010 | 1204 | 0.010 |
Why?
|
Mutation | 2 | 2000 | 30053 | 0.010 |
Why?
|
Liver Cirrhosis | 1 | 2015 | 1935 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2019 | 12463 | 0.010 |
Why?
|
Professional Competence | 1 | 2007 | 431 | 0.010 |
Why?
|
Blood Coagulation Disorders | 1 | 2007 | 350 | 0.010 |
Why?
|
Gene Amplification | 1 | 1988 | 1089 | 0.010 |
Why?
|
Growth Substances | 1 | 2006 | 768 | 0.010 |
Why?
|
Phosphotransferases (Alcohol Group Acceptor) | 1 | 2006 | 435 | 0.010 |
Why?
|
Adolescent | 2 | 2010 | 88326 | 0.010 |
Why?
|
Blood Proteins | 1 | 2009 | 1173 | 0.010 |
Why?
|
Echoencephalography | 1 | 2003 | 134 | 0.010 |
Why?
|
Prosthesis Design | 1 | 2010 | 2115 | 0.010 |
Why?
|
Melanoma, Experimental | 1 | 2006 | 561 | 0.010 |
Why?
|
Purpura | 1 | 2003 | 117 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2015 | 10766 | 0.010 |
Why?
|
Fibronectins | 1 | 2006 | 723 | 0.010 |
Why?
|
Monocytes | 1 | 1992 | 2570 | 0.010 |
Why?
|
Tissue Distribution | 1 | 2006 | 2264 | 0.010 |
Why?
|
Protein Isoforms | 1 | 2006 | 1699 | 0.010 |
Why?
|
Incidence | 1 | 2019 | 21355 | 0.010 |
Why?
|
Cytoskeletal Proteins | 1 | 2006 | 1342 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 1998 | 11904 | 0.010 |
Why?
|
Health Care Surveys | 1 | 2007 | 2426 | 0.010 |
Why?
|
Binding Sites | 1 | 2009 | 6056 | 0.010 |
Why?
|
Cell Adhesion Molecules | 1 | 2006 | 1601 | 0.010 |
Why?
|
Gene Silencing | 1 | 2006 | 1509 | 0.010 |
Why?
|
Reoperation | 1 | 2010 | 4303 | 0.010 |
Why?
|
Fetal Growth Retardation | 1 | 2003 | 580 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2006 | 3792 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2010 | 5247 | 0.010 |
Why?
|
Cytomegalovirus | 1 | 2003 | 756 | 0.010 |
Why?
|
Medical Errors | 1 | 2007 | 1263 | 0.010 |
Why?
|
Data Collection | 1 | 2007 | 3322 | 0.010 |
Why?
|
Neoplasm Invasiveness | 1 | 2006 | 3597 | 0.010 |
Why?
|
Child, Preschool | 1 | 2020 | 42232 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2015 | 7391 | 0.010 |
Why?
|
RNA, Small Interfering | 1 | 2006 | 3430 | 0.010 |
Why?
|
Cell Membrane | 1 | 2006 | 3687 | 0.010 |
Why?
|
Protein Binding | 1 | 2009 | 9353 | 0.010 |
Why?
|
United States | 1 | 2003 | 72340 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 1992 | 10194 | 0.010 |
Why?
|
Placenta | 1 | 2003 | 1709 | 0.010 |
Why?
|
Cell Movement | 1 | 2006 | 5205 | 0.010 |
Why?
|
Carrier Proteins | 1 | 2006 | 4937 | 0.010 |
Why?
|
Quality of Health Care | 1 | 2007 | 4331 | 0.010 |
Why?
|
Anticoagulants | 1 | 2007 | 4812 | 0.010 |
Why?
|
Prospective Studies | 1 | 2016 | 54423 | 0.010 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2003 | 2151 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2007 | 14608 | 0.010 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 1992 | 1058 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2006 | 18966 | 0.010 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 1 | 1992 | 473 | 0.010 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 1992 | 477 | 0.010 |
Why?
|
Risk Assessment | 1 | 2010 | 23996 | 0.000 |
Why?
|
DNA, Neoplasm | 1 | 1992 | 1745 | 0.000 |
Why?
|
Mice | 2 | 2006 | 81539 | 0.000 |
Why?
|
Infant, Newborn | 1 | 2003 | 26202 | 0.000 |
Why?
|
Amino Acid Sequence | 1 | 1992 | 13446 | 0.000 |
Why?
|
Cell Line | 1 | 1992 | 15601 | 0.000 |
Why?
|
Rats | 1 | 1992 | 23741 | 0.000 |
Why?
|